Impact of inhaled fluticasone propionate/salmeterol on health-related quality of life in asthma: A network meta-analysis

被引:4
作者
Maneechotesuwan, Kittipong [1 ]
Singh, Dave [2 ,3 ]
Fritscher, Leandro G. [4 ]
Dursunoglu, Nese [5 ]
Abhijith, P. G. [6 ]
Phansalkar, Abhay [7 ]
Aggarwal, Bhumika [6 ]
Pizzichini, Emilio [8 ]
Chorazy, Justyna [9 ]
Burnett, Heather [9 ]
机构
[1] Mahidol Univ, Dept Med, Div Resp Dis & TB, Bangkok, Thailand
[2] Univ Manchester, Manchester, Lancs, England
[3] Manchester Univ NHS Fdn Trust, Manchester, Lancs, England
[4] Pontif Catholic Univ PUCRS, Fac Med, Porto Alegre, RS, Brazil
[5] Pamukkale Univ, Dept Chest Dis, Sch Med, Denizli, Turkey
[6] GSK, Singapore 139234, Singapore
[7] GSK, Mumbai, Maharashtra, India
[8] GSK, Brentford, Middx, England
[9] Evidera, Needham, MA USA
关键词
Asthma quality of life questionnaire; ICS/LABA; Network meta-analysis; Systematic review; MU-G COMBINATION; DOUBLE-BLIND; SALMETEROL/FLUTICASONE PROPIONATE; BUDESONIDE/FORMOTEROL MAINTENANCE; CONTROL QUESTIONNAIRE; UNCONTROLLED ASTHMA; RELIEVER THERAPY; MODERATE; SALMETEROL; FORMOTEROL;
D O I
10.1016/j.rmed.2022.106993
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: This network meta-analysis (NMA) compared fixed-dose, twice daily fluticasone propionate/salmeterol (FP/Sal) vs. inhaled corticostemid (ICS) and other ICS/long-acting beta-agonists (LABA) treatments, including when administered using maintenance and reliever therapy (MART) regimens, in terms of improvements in health-related quality of life (HRQoL). The relationship between changes in asthma control and HRQoL was assessed. Methods: Articles published between 2001 and 2021, reporting change from baseline (CFB) in Asthma Quality of Life Questionnaire (AQLQ) in patients with moderate-to-severe asthma, were identified by a systematic review. Random effects Bayesian NMAs derived estimates of the mean difference in CFB in AQLQ vs. other interventions connected to the network (included 15 studies). Sensitivity analyses explored the impacts of differences in follow-up duration, baseline asthma control, the inclusion of observational studies, adjusting for baseline FEV1, and low-medium ICS dose arms only. Linear regression analysis compared CFBs in AQLQ and Asthma Control Questionnaire (ACQ) score. Results: Mean CFB in AQLQ with FP/Sal vs. comparators demonstrated expected ranked effects: mean difference 0.65 [95% credible interval: 0.54, 0.78] versus placebo, 0.58 [0.33, 0.84] versus LABA, 0.21 [0.13, 0.31] versus ICS alone, 0.06 [-0.04, 0.19] versus other ICS/LABA, and 0.00 [-0.13, 0.14] versus ICS/formoterol MART. Sensitivity analyses largely showed consistent results. Improvements in AQLQ and ACQ were strongly correlated (R = 0.94). Conclusions: This NMA demonstrates that HRQoL is responsive to treatment, is strongly related to asthma control and that it can be well-managed in patients with moderate-to-severe asthma using regular treatment with inhaled FP/Sal.
引用
收藏
页数:10
相关论文
共 75 条
[1]   Asia-Pacific Survey of Physicians on Asthma and Allergic Rhinitis (ASPAIR): physician beliefs and practices about diagnosis, assessment, and treatment of coexistent disease [J].
Aggarwal, Bhumika ;
Shantakumar, Sumitra ;
Hinds, David ;
Mulgirigama, Aruni .
JOURNAL OF ASTHMA AND ALLERGY, 2018, 11 :293-307
[2]   The Asthma Control Questionnaire as a clinical trial endpoint: past experience and recommendations for future use [J].
Barnes, P. J. ;
Casale, T. B. ;
Dahl, R. ;
Pavord, I. D. ;
Wechsler, M. E. .
ALLERGY, 2014, 69 (09) :1119-1140
[3]   Asthma control and quality of life in patients with moderate or severe asthma [J].
Barros Pereira, Eanes Delgado ;
de Matos Cavalcante, Antonio George ;
Silva Pereira, Eduardo Nolla ;
Lucas, Pedro ;
Holanda, Marcelo Alcantara .
JORNAL BRASILEIRO DE PNEUMOLOGIA, 2011, 37 (06) :705-711
[4]   The correlation between asthma control and health status: the GOAL study [J].
Bateman, E. D. ;
Bousquet, J. ;
Keech, M. L. ;
Busse, W. W. ;
Clark, T. J. H. ;
Pedersen, S. E. .
EUROPEAN RESPIRATORY JOURNAL, 2007, 29 (01) :56-63
[5]   Can guideline-defined asthma control be achieved? The gaining optimal asthma control study [J].
Bateman, ED ;
Boushey, HA ;
Bousquet, J ;
Busse, WW ;
Clark, TJH ;
Pauwels, RA ;
Pedersen, SE .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (08) :836-844
[6]   Global Initiative for Asthma 2016-derived asthma control with fluticasone propionate and salmeterol A Gaining Optimal Asthma Control (GOAL) study reanalysis [J].
Bateman, Eric D. ;
Busse, William ;
Pedersen, Soren E. ;
Bousquet, Jean ;
Huang, Shaoguang ;
Zhou, Xin ;
Gul, Nadeem ;
Hollis, Sally ;
Gibbs, Michael .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (01) :57-+
[7]   Magnitude of effect of asthma treatments on Asthma Quality of Life Questionnaire and Asthma Control Questionnaire scores: Systematic review and network meta-analysis [J].
Bateman, Eric D. ;
Esser, Dirk ;
Chirila, Costel ;
Fernandez, Maria ;
Fowler, Andy ;
Moroni-Zentgraf, Petra ;
FitzGerald, J. Mark .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 136 (04) :914-922
[8]  
Bergmann KC, 2004, SWISS MED WKLY, V134, P50
[9]  
Bodzenta-Lukaszyk Anna, 2012, J Asthma, V49, P1060, DOI 10.3109/02770903.2012.719253
[10]   Efficacy and safety of fluticasone and formoterol in a single pressurized metered dose inhaler [J].
Bodzenta-Lukaszyk, Anna ;
Pulka, Grazyna ;
Dymek, Andrzej ;
Bumbacea, Dragos ;
McIver, Tammy ;
Schwab, Birgit ;
Mansikka, Heikki .
RESPIRATORY MEDICINE, 2011, 105 (05) :674-682